Radiotherapy
Apr29

Precision targeted radiotherapy for cancer: current and future paradigms

Dr. Billy W. Loo, Stanford

-

Abstract: Radiation therapy has become one of the most effective and cost effective precision targeted cancer therapies. This colloquium
will review the evolution of radiotherapy in recent years, and highlight future directions in its continued evolution towards more
effective cure of cancer.

About Dr. Billy W. Loo

Billy Loo Headshot

Billy W. Loo Jr., MD PhD is a Professor of Radiation Oncology, a member of the Stanford Cancer Institute, of the Molecular Imaging Program at Stanford (MIPS), and of Bio-X. He is a physician-scientist Radiation Oncologist and Bioengineer who directs the Thoracic Radiation Oncology Program and is Principal Investigator of the FLASH Sciences Lab @Stanford. His clinical specialty is state-of-the-art precision radiotherapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR). Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, particularly the National Comprehensive Cancer Network (NCCN).

Audience:

In case you're interested

Upcoming events

Abstract: In this talk we will present an update on the Lab’s science and technology strategy, which has been under development for the past...
Update on SLAC’s Science & Technology Strategy Graphic
May13
Abstract: The invention of attosecond light sources using high-harmonic generation  has inspired a new field of research. Attosecond science is concerned with the study...
Attosecond X-ray Free-Electron Lasers
May20